Microsoft exec to become Providence St. Joseph CFO

Renton, Wash.-based Providence St. Joseph Health found its new CFO from the executive ranks at another large Washington company, Microsoft, hiring the tech giant’s managing director for business development and growth strategy, Venkat Bhamidipati.

“By selecting Venkat, we are making an intentional pivot for our organization that will support the intersection between technology and health care, ultimately leading to better patient care,” Providence St. Joseph CEO Rod Hochman, MD, said in a statement. “With his depth of experience, Venkat will help guide us as we pursue innovative new offerings that will make our services more convenient and affordable while also generating new revenue streams to support our mission.”

Bhamidipati had been at Microsoft for 13 years, starting as general manager of finance in its worldwide operations group in 2004. His resume doesn’t include any prior experience at hospitals or health systems.

Providence St. Joseph emphasized his tech experience in selecting him for the role, which it said will involve assisting the system in “making solid investments to ensure it continues as an outstanding and innovative health care provider.”

“No sector of the American economy is more dynamic or integral to peoples’ lives as health care. And no single health care organization is more embracing of the role of technology in health than Providence St. Joseph Health,” Bhamidipati said. “I was attracted to Providence St. Joseph Health because of its mission and dedication to the physical, spiritual and social needs of its communities. I am also excited to use my experience at one of the world’s leading technology companies to help Providence accelerate health care innovation.”

Bhamidipati will assume the CFO role for the 50-hospital system on July 31. Interim CFO Jo Ann Escasa-Haigh is set to transition to a new role as CFO of operations, overseeing financial officers at the regional, medical group and home health level within the company.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.